Navigation Links
FDA Approves Cymbalta(R) for the Management of Fibromyalgia
Date:6/16/2008

he dose and if they are pregnant or nursing.

Patients taking Cymbalta may experience dizziness or fainting upon standing. The most common side effects of Cymbalta include nausea, dry mouth, sleepiness, and constipation. This is not a complete list of side effects.

If patients have any questions, they should talk to their doctor before taking Cymbalta.

For full Patient Information, visit http://www.cymbalta.com.

For full Prescribing Information, including Boxed Warning and medication guide, visit http://www.cymbalta.com.

About Eli Lilly and Company

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of first-in-class and best-in-class pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers - through medicines and information - for some of the world's most urgent medical needs. Additional information about Lilly is available at http://www.lilly.com.

P-LLY

This press release contains forward-looking statements about the potential of Cymbalta for the management of fibromyalgia, and reflects Lilly's current beliefs. However, as with any pharmaceutical product, there are substantial risks and uncertainties in the process of development and commercialization. There is no guarantee that the product will continue to be commercially successful. For further discussion of these and other risks and uncertainties, see Lilly's filings with the United States Securities and Exchange Commission. Lilly undertakes no duty to update forward-looking statements.

(i) Leventhal, LJ. "Management of fibromyalgia." Annals of Internal Medicine. 1999; 131: 850-858.

(ii) Arnold, L, et al. "Fa
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. ClearWay Minnesota(SM) Board Approves $1.4 Million in New Grants to Reduce Tobaccos Harm
2. FDA Approves AstraZenecas Seroquel(R) for Maintenance Treatment in Bipolar Disorder
3. FDA Approves NOVO NORDISKs NovoSeven(R) RT (Coagulation Factor VIIa [Recombinant] Room Temperature Stable) for Hemophilia Patients With Inhibitors
4. FDA Approves Taclonex Scalp(R) - Once Daily Therapy for Treatment of Moderate to Severe Scalp Psoriasis
5. FDA Approves Health Claim for Brown Rice
6. FDA Approves Strattera(R) for Maintenance of ADHD in Children and Adolescents
7. FDA approves HeartMate II mechanical heart pump for heart-failure patients
8. FDA Approves Advair(R) 250/50 for Reduction of Exacerbations in Patients With COPD
9. FDA Approves New Once-a-Month Dose of Actonel for Postmenopausal Osteoporosis
10. FDA approves VYVANSE, first and only once-daily prodrug stimulant to treat ADHD in adults
11. FDA APPROVES ROTARIX(R) [Rotavirus Vaccine, live, oral], THE FIRST VACCINE LICENSED TO COMPLETE THE ROTAVIRUS IMMUNIZATION SERIES BY FOUR MONTHS OF AGE
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... Gateway Building Concepts is experienced with all ... company specialize in include decks, additions, kitchen remodeling, interior ... much more. , The redesigned logo is a ... company. It includes two geometrical lines that represent the ... to be used with many things associated with the ...
(Date:5/22/2015)... 22, 2015 A Phase 3 ... American Society of Clinical Oncology (ASCO)’s annual meeting ... rates for those patients who received bevacizumab in ... pemetrexed/cisplatin. Bevacizumab (Avastin® Genentech, Inc.) is an antibody ... is already routinely used to treat many other ...
(Date:5/22/2015)... Ticket Down is a reputable source for authentic ... Finals Tickets . All seating for the 2015 NHL ... listing. , For the first time in some time, ... Eastern Conference. One of the original franchises in the National ... over the years, but the excitement level for this season ...
(Date:5/22/2015)... In April 2006, Veatch Consulting opened ... years they have concentrated their focus to working with ... Because of this growth and their goals to better ... Denver, Colorado, Cleveland, Ohio, Houston, Texas and now Dallas, ... dental offices, dental start ups, orthodontic practices, pediatric dental ...
(Date:5/22/2015)... 2015 Bryce Henson, local fitness icon ... Boot Camp, recently accepted his program’s 100th client. Henson ... launch of his location evidences the powerful impact his ... Fit Body Boot Camp is the nation’s most popular ... hundreds of locations across North America, Europe and Australia. ...
Breaking Medicine News(10 mins):Health News:Mesothelioma Research Organization Excited About Imminent Improvement to Standard of Care 2Health News:Cheap Lightning vs Rangers NHL Eastern Conference Finals Tickets: Ticket Down Slashes Ticket Prices on New York Rangers vs Tampa Bay Lightning Eastern Conference Playoffs 2Health News:Cheap Lightning vs Rangers NHL Eastern Conference Finals Tickets: Ticket Down Slashes Ticket Prices on New York Rangers vs Tampa Bay Lightning Eastern Conference Playoffs 3Health News:Healthy Living Brought to Anaheim— New Fitness Boot Camp Acquires 100 Clients 2
... related to trend toward less sleep, researchers suspect ... many reasons why people should get adequate sleep, researchers now ... a component of type 2 diabetes. , The study included ... night of normal sleep (about eight hours) and after a ...
... ... "super chocolate", has been found effective in aiding weight loss. Users say it helps ... ... 2010 -- A special formulation of "super chocolate" has been fast increasing popularity among ...
... is safe, improves blood sugar control , THURSDAY, May ... have been encapsulated have been successfully transplanted into humans ... cells. , What,s more, scientists report, the transplanted pig ... to high blood sugar levels in the blood, improving ...
... Spring Harbor Laboratory in the USA have developed a powerful ... The breakthrough allows them to study in fine detail the ... help doctors identify dangerous tumor cells from small samples such ... in the breast. Dr James Hicks from Cold Spring ...
... study of metastatic breast cancer shows that the number ... directly correlates with the length of their survival. Reported ... the results have the potential to improve the delivery ... cells --cancer cells found in a patient,s bloodstream-- are ...
... to 10 million women take hormone therapies, which are ... hormones lost from inactive ovaries. Progestin is a hormone ... of estrogen therapy on the uterus. In studies sponsored ... found that estrogen and progestin in hormone therapies increase ...
Cached Medicine News:Health News:One Sleepless Night Ups Insulin Resistance 2Health News:Super Fat-Melting Chocolate Recipe Revealed 2Health News:Super Fat-Melting Chocolate Recipe Revealed 3Health News:Pig Pancreas Cells Help Type 1 Diabetics 2Health News:Pig Pancreas Cells Help Type 1 Diabetics 3Health News:Genome breakthrough allows scientists to identify and profile tumor cells from very small samples 2Health News:Survival in metastatic breast cancer directly linked to circulating tumor cells 2Health News:Breast cancer metastasis increases after estrogen and progestin hormone therapies, MU study finds 2
(Date:5/22/2015)... Texas , May 22, 2015 ... million in 2014 and is estimated to reach $90.7 million ... 2019. Browse through the TOC of North America ... segments, with the help of various tables and figures. ... receive 10% customization on this report.   ...
(Date:5/22/2015)... Md. , May 22, 2015  RegeneRx Biopharmaceuticals, ... on tissue protection, repair and regeneration, today announced that ... is scheduled to present a corporate overview at two ... present at the SeeThruEquity 4 th Annual Microcap ... New York City at 11:00 am EDT. ...
(Date:5/22/2015)... , May 22, 2015  The U.S. ... Zarxio (filgrastim-sndz) -- the first biosimilar product approved ... -- points toward growth in the contract manufacturing ... mainstream CMO industry is geared to the production ... produce major biopharmaceutical products. The healthcare market research ...
Breaking Medicine Technology:North America Dental Lasers Market is Expected to Reach $90.7 Million by 2019, at a CAGR of 9.2% From 2014 to 2019 2North America Dental Lasers Market is Expected to Reach $90.7 Million by 2019, at a CAGR of 9.2% From 2014 to 2019 3RegeneRx to Present at 2 Investor Conferences 2RegeneRx to Present at 2 Investor Conferences 3Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 2Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 3Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 4
... 18, 2011 Bexion Pharmaceuticals was named the Biotech ... program sponsored by the Cincinnati Business Courier, the Cincinnati ... outstanding innovation and the companies and people who have ... for the regional Tri-State (Ohio/Kentucky/Indiana) economic engine. ...
... Md., April 18, 2011 Science, public ... Food and Drug Administration. I nformation in this document ... items are current as of April 18, 2011. ... & Notes does not contain any regulatory or enforcement actions ...
Cached Medicine Technology:Bexion Pharmaceuticals Receives Outstanding Biotech Innovation Award 2FDA News & Notes - Week of April 18, 2011 2
... your practice with a practice management system. ... or on paper. Your patient statements can also ... has a combined traditional software and billing services ... any computer from anywhere - multiples offices or ...
... 3 mirrors angled at 76°, 66° and 60°. ... as well as central and peripheral fundus viewing ... accurately angled and spaced 120° apart to eliminate ... portion of the lens also provides direct observation ...
... Volk 3 mirror lenses featuring ultra-clear Volk ... at 76°, 66° and 60°. The ... as well central and peripheral fundus viewing ... accurately angled to eliminate gaps in the ...
... is a direct image lens ... air-filled eye. In addition to ... air-fluid exchange vitrectomy lens, the ... make it well suited for ...
Medicine Products: